Health Care & Life Sciences » Pharmaceuticals | Jeil Pharmaceutical Co. Ltd.

Jeil Pharmaceutical Co. Ltd.

Jeil Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1199.35
Market Cap
KRW334.66 B
Shares Outstanding
15.97 M
Public Float
2.19 M

Profile

Address
343 Sapyeong-daero
Seoul SL 06543
Korea, Republic Of
Employees -
Website -
Updated 07/08/2019
Jeil Pharma Holdings, Inc. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients and finished dosage forms. The active pharmaceutical ingredients provide medicines for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, and musculoskeletal.

Financials

View All
Created with Highcharts 5.0.14Jeil Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.4844842 0952 0959 7619 7612 1782 1783 5023 5027 0707 07020132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Jeil Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.451 968451 968512 736512 736594 716594 71640 60440 60444 44144 441137 609137 6092013201420152016201720180100k200k300k400k500k600k700k

Sang-Cheol Han
Chief Executive Officer & Director
Seok-Jae Sung
President & Director